Telum Therapeutics SL

Telum Therapeutics is a biotechnology company based in Spain dedicated to developing innovative antimicrobial therapies for the treatment of severe multidrugresistant bacterial infections. The Company’s proprietary APEX® platform enables the discovery and development of novel biologically derived, protein-based antimicrobial candidates targeting clinically important Gram-negative and Grampositive pathogens. Telum’s lead program is being developed for the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by Acinetobacter baumannii.